Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache

Current Medical Research and Opinion

Volumn 22, Issue 8, 2006, Pages 1535-1544

  Kaniecki, Robert ^a   Ruoff, Gary ^b   Smith, Timothy ^c   Barrett, Pamela S ^d   Ames, Michael H ^d   Byrd, Susan ^d   Kori, Shashidhar ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Ryan Headache Center   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Headache; Migraine; Sumatriptan

Indexed keywords

IBUPROFEN; PARACETAMOL; PLACEBO; SUM 40312; SUMATRIPTAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVALUATION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; PREVALENCE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SCREENING; SELF REPORT; SYMPTOMATOLOGY; TABLET; TENSION HEADACHE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SELECTION; PLACEBOS; PREVALENCE; SELF ASSESSMENT (PSYCHOLOGY); SELF-ASSESSMENT; SUMATRIPTAN; TENSION-TYPE HEADACHE; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 33748090566     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X115685     Document Type: Article

References (27)

1. Tepper SJ, Dahlöf CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the landmark study. Headache 2004;44:856-64
2. Sheftell FD, Tepper SF. New paradigms in the recognition and acute treatment of migraine. Headache 2002;42:58-69
3. Smith TR. Pitfalls in migraine diagnosis and management. Clin Cornerstone 2001;4:26-35
4. Cady R, Dodick DW. Diagnosis and treatment of migraine. Mayo Clin Proc 2002;77:255-61
5. Landy S. Migraine throughout the life cycle: treatment through the ages. Neurology 2004;62(5 Suppl 2):S2-S8
6. Dowson AJ, Sender J, Lipscombe S, et al. Establishing principles for migraine management in primary care. Int J Clin Pract 2003;57:493-507
7. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-57
8. Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001;41:638-45
9. Kaniecki RG. Migraine and tension-type headache: an assessment of challenges in diagnosis. Neurology 2002;58(Suppl 6):S15-S20
10. Headache Classification Committee ot the International Headache Society. The international classification of headache disorders [2nd ed]. Cephalalgia 2003;24(Suppl 1):1-151
11. Inan LE, Tulunay FC, Guvener A, et al. Characteristics of headache in migraine without aura and episodic tension-type headache in the Turkish population according to the IHS classification. Cephalalgia 1994;14:171-3
12. Spierings ELH, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache 2001;41:554-8
13. Kaniecki RG, Totten J. Cervicalgia in migraine: prevalence, clinical characteristics, and response to treatment. Poster presented at the 10th Congress of the International Headache Society; June 29-July 2, 2001; New York, New York.
14. Headache Classification Committee of the International Headache Society. Classification of headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1-96
15. Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003;12:963-74
16. Kaniecki RG. Diagnostic challenges in headache: migraine as the wolf disguised in sheep's clothing. Neurology 2002;58(Suppl 6): S1-S2
17. 1-like receptor agonists and the pathophysiology of migraine. Trends Pharmacol Sci 1989;10:200-4
18. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on cerebral circulation. J Cereb Blood Flow Metab 1999;19:115-27
19. Hargreaves RJ, Shepheard SL. Pathophysiology of migraine-new insights. Can J Neurol Sci 1999;26:S12-S19
20. Cady RK, Sheftell F, Lipton RB, et al. Effects of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000;22:1035-48
21. Winner P, Mannix LK, Putnam DG, et al. Pain-tree results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies. Mayo Clin Proc 2003;78:1214-22
22. Cady RK, Lipton RB, Hall C, et al. Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache 2000;40:792-7
23. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614-24
24. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack. Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000;123:1703-9
25. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 2004;55:27-36
26. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004;55:19-26
27. Yarnitsky D, Goor-Aryeh I, Bajwa ZH, et al. 2003 Wolff Award: possible parasympathetic contributions to peripheral and central sensitization during migraine. Headache 2003;43:704-14